Shaolin Capital Management LLC Sab Biotherapeutics, Inc. Transaction History

Shaolin Capital Management LLC

  • $1.35 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
SELL
$0.54 - $9.8 $20,724 - $376,114
-38,379 Reduced 13.96%
236,621 $140,000
Q1 2022

May 13, 2022
BUY
$1.78 - $8.5 $62,745 - $299,625
35,250 Added 14.7%
275,000 $1.03 Million
Q4 2021

Feb 14, 2022
BUY
$7.3 - $11.24 $1.75 Million - $2.69 Million
239,750 New
239,750 $1.87 Million

Others Institutions Holding SABS

# of Institutions
3
Shares Held
529K
Call Options Held
0
Put Options Held
0
View Full List

About SAB Biotherapeutics, Inc.

SABS Quotes by TradingView
  • Ticker SABS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,030,900
  • Market Cap $172M
  • Description
  • SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies based on human antibodies. It has applied advanced genetic engineering and antibody science to develop transchromosomic bovine herds that produce fully human antibodies targeted at specific diseases, including infectious diseases ...
More about SABS
Track This Portfolio

Track Shaolin Capital Management LLC Portfolio

Follow Shaolin Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shaolin Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Shaolin Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email